Top Pharmaceuticals stocks in United States
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $731.81bn | 69.47 | 0.61% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $372.17bn | 16.58 | 3.08% |
MRKMerck & Co | $332.28bn | 57.1 | 2.29% |
ABBVAbbvie | $293.88bn | 32.88 | 3.6% |
AMGNAmgen | $167.62bn | 44.38 | 2.77% |
PFEPfizer | $162.29bn | 10.21 | 5.76% |
CELG RTBristol-Myers Squibb Co | $89.25bn | 0.01 | 4162.16% |
BMYBristol-Myers Squibb Co | $89.25bn | 11.74 | 5.25% |
GILDGilead Sciences | $84.37bn | 12.07 | 4.46% |
ZTSZoetis | $79.42bn | 33.22 | 0.89% |
MCKMcKesson | $73.38bn | 25.15 | 0.41% |
BIIBBiogen | $33.57bn | 24.93 | n/a |
HZNPHorizon Therapeutics | $26.63bn | 51.44 | n/a |
CAHCardinal Health | $24.13bn | 18.74 | 2.02% |
RPRXRoyalty Pharma | $16.29bn | 15.3 | 2.97% |
BMRNBiomarin Pharmaceutical | $14.73bn | 73.49 | n/a |
VTRSViatris | $13.07bn | 21.98 | 4.37% |
INCYIncyte | $12.82bn | 16.92 | n/a |
CTLTCatalent | $10.02bn | n/a | n/a |